Evidence map›Paper›PMID 32199130›Full record

ArticleMolecular therapy. Nucleic acids2020

miR-122 Exerts Inhibitory Effects on Osteoblast Proliferation/Differentiation in Osteoporosis by Activating the PCP4-Mediated JNK Pathway.

Yi-Chen Meng, Tao Lin, Heng Jiang, Zheng Zhang, Lun Shu, Jia Yin, Xiao Ma, Ce Wang, Rui Gao, Xu-Hui Zhou

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. The characteristic expression of circulatingFrontiers in endocrinology · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yi-Chen MengDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Tao LinDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Heng JiangDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Zheng ZhangDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Lun ShuDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Jia YinDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Xiao MaDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Ce WangDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Rui GaoDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Xu-Hui ZhouDepartment of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China. Electronic address: zhouxuhui@smmu.edu.cn.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is characterized by the reduction of bone mineral density and deterioration of bone quality which leads to high risk of fractures. Some microRNAs (miRNAs) have been confirmed as potential modulators of osteoblast differentiation to maintain bone mass maintenance. We aimed to clarify whether miR-122 could regulate osteoblast differentiation in ovariectomized rats with osteoporosis. miR-122 was upregulated and Purkinje cell protein 4 (PCP4) was downregulated in ovariectomized rats. PCP4 was identified as a target of miR-122 by dual-luciferase reporter gene assay. We transfected isolated osteoblasts from ovariectomized rats with miR-122 mimic or inhibitor or PCP4 overexpression vectors. Proliferation and differentiation of osteoblasts were repressed by the overexpression of miR-122 but enhanced by overexpression of PCP4. miR-122 could induce the activation of the c-Jun NH2-terminal kinase (JNK) signaling pathway, while PCP4 blocked this pathway. Rescue experiments further demonstrated that the inhibiting effects of miR-122 on osteoblast differentiation could be compensated by activation of the PCP4 or inhibition of JNK signaling pathway. Collectively, our data imply that miR-122 inhibits osteoblast proliferation and differentiation in rats with osteoporosis, highlighting a novel therapeutic target for osteoporotic patients.

Indexed as

JNK signaling pathwaymicroRNA-122osteoblastsosteoporosisPCP4proliferation

Identifiers

PMID32199130
PMCPMC7082497
OpenAlexW2998864968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.